Evolve Biologics Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Mississauga ON Canada

Primary Industry

Biotechnology

About

Founded in 2018 and based in Ontario, Canada, Evolve Biologics Inc. is a provider of patented technology for plasma-derived therapeutics. The company was created as a division of Theropure Biopharma Inc. in 2018. The company leverages its technology to provide higher levels of purity, efficiency, and reliability in critical plasma-derived therapeutics. The core technology of the company is its patented PlasmaCap EBA which is used in the process of plasma protein extraction. The team of the company is comprised of researchers a management tem with experience in the therapeutics industry. The company has commercialized intravenous immunoglobulin and human serum albumin in the U.S. and Canada markets. The company is currently working on the construction of its first commercial facility in the US, which is expected to be completed in spring 2021. The goal of the company is to help deliver plasma proteins at improved levels of quality and purity in comparison to traditional methods.

Current Investors

The Catalyst Capital Group

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.evolvebiologics.com

Verticals

HealthTech

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

Deals

Deals Type
Growth

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Evolve Biologics Inc.	10 Mar 2021

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.